Cardio-renal Metabolic Disease (CVRM) The Growing Role of Pharmacists in Managing Multi-Morbidities

Our study days are sponsored by pharmaceutical companies, who provide funding that allows us to offer all events completely free of charge. Sponsors have no involvement in agenda development, speaker selection, or clinical content – this is managed entirely by MORPh’s clinical team.

The “Cardio-renal Metabolic Disease (CVRM) The Growing Role of Pharmacists in Managing Multi-Morbidities”  Study Day is free to access for all registered healthcare professionals that have a MORPh Account.

Doors will open at 09:00 for welcome and introductions the study day will begin shortly after. Our expert speakers will be discussing the following topics:

Learning Objectives 

By the end of this session, delegates will be able to: 

• Demonstrate person-centred consultation skills, including shared decision-making, and culturally sensitive approaches to support diverse patient populations. 
• Optimise medicines for people with multimorbidity, across the entire spectrum of Cardiovascular-Renal-Metabolic diseases 
• Integrate holistic and preventative approaches into chronic disease management, addressing health inequalities, non-pharmacological options, and appropriate signposting. 
• Recognise when maintaining current therapy, deprescribing, or making no change is clinically appropriate. 
• Understanding the principals of cardiovascular risk, early prevention and management to optimise long term goals 

Hypertension, the holy grail of cardiovascular disease 

• Hypertension overview 
• Identification, Diagnosis and Management of Hypertension in primary care 
• Secondary hypertension, how to better screen patients and reduce inappropriate referrals 
• Resistant hypertension, how to manage patients in primary care 
• Practical methods of implementing the latest guidelines 

Lipids, the causal risk factor to cardiovascular disease 

•  An overview of lipids and atherosclerotic cardiovascular disease 
• Understanding cardiovascular risk and the differential between primary and secondary prevention 
• Targets: how to achieve them realistically, and how they can differ  
• Treatment options and practical methods of implementation 

Chronic Kidney Disease, the hidden risk factor  

• An overview of CKD and its significance in cardiovascular risk 
• Identification, Diagnosis and Management of CKD 
• The importance of urine ACR and its role as an independent risk factor 
• KFRE and when to refer 
• Practical methods of improving CKD management in primary care